Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT03896243

Collaborator

(none)

102

Enrollment

Location

Actual Duration (Months)

7.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Investigators would like to see the amh values after uterine artery ligation

Condition or Disease	Intervention/Treatment	Phase
Uterine Artery Ligation Ovarian Reserve	Diagnostic Test: Uterine artery ligation (UAL)

Detailed Description

Group/cohort:

Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Control Group:

Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.

Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Study Design

Study Type:

Observational

Actual Enrollment :

102 participants

Observational Model:

Case-Control

Time Perspective:

Retrospective

Official Title:

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Actual Study Start Date :

Jan 1, 2018

Actual Primary Completion Date :

Jan 1, 2019

Actual Study Completion Date :

Feb 1, 2019

Arms and Interventions

Arm	Intervention/Treatment
Uterine artery ligation (UAL) We would like toinvite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)	Diagnostic Test: Uterine artery ligation (UAL) Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Control Group: We would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication. They would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)	Diagnostic Test: Uterine artery ligation (UAL) Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Arm

Intervention/Treatment

Uterine artery ligation (UAL)

We would like toinvite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Diagnostic Test: Uterine artery ligation (UAL)

Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Control Group:

We would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication. They would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Diagnostic Test: Uterine artery ligation (UAL)

Outcome Measures

Primary Outcome Measures

1.ovarian reserve in patients with uterine artery ligation [12 months]
calculation of ovarian reserve with amh (ng/ml) after uterine artery ligation due to uterine atony

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 35 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

age 18- 35 years
no systemic or endocrine diseases
patients who had uterine artery ligation due to atony
healthy postpartum patients as controls

Exclusion Criteria:

patients with PCOS
Pregnancy with IVF or oosit donation
Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.
Patients with BMI >40

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Pinar Yalcin Bahat	Istanbul	İ̇stanbul	Turkey	34000

Sponsors and Collaborators

Kanuni Sultan Suleyman Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital

ClinicalTrials.gov Identifier:

NCT03896243

Other Study ID Numbers:

uterinarter

First Posted:

Mar 29, 2019

Last Update Posted:

Mar 29, 2019

Last Verified:

Mar 1, 2019

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital

Uterine atony

amh

Study Results

No Results Posted as of Mar 29, 2019